Supplementary Online Content

Similar documents
Appendix K: Evidence review flow charts

Supplementary Online Content

Supplementary Online Content

Supplementary Online Content

Supplementary Online Content

Nebraska Medicaid Criteria. Abilify Maintena

Supplementary Online Content

Effect of Depression and Diabetes Mellitus on the Risk for Dementia A National Population-Based Cohort Study

Supplementary Materials for

Supplementary Online Content

Supplementary Online Content

Supplementary Appendix

Supplementary Online Content

Definitions of chronic conditions used to define the number of serious comorbidities in the study.

Use of Anti-Psychotic Agents in Irish Long Term Care Residents with Dementia

Disclosure. Speaker Bureaus. Grant Support. Pfizer Forest Norvartis. Pan American Health Organization/WHO NIA HRSA

Supplementary Online Content

Supplementary Online Content

Next patient please Dementia Clare Hawley 2018

SUPPLEMENTAL MATERIAL

Supplementary Online Content

Supplementary Online Content

Epidemiology Old Age

Dementia is not normal aging!

Supplementary Online Content

BlueCare Tennessee Practice Guidance For the Treatment of Schizophrenia Kelly Askins, MD and Deborah Gatlin, MD 3/9/2015 Reviewed: February, 2017

efigure. Directed Acyclic Graph to Determine Whether Familial Factors Exist That Contribute to Both Eating Disorders and Suicide

W. De La Haye, M.D., M.P.H., D.M. Department of Community Health & Psychiatry, The University of the West Indies, Mona Campus, JAMAICA

Supplementary Online Content

Integrated Four Quadrant Model: Behavioral and Physical Health. UIC College of Nursing

Supplementary Online Content

Mental Health Disorders Civil Commitment UNC School of Government

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE. Health Technology Appraisal

Understanding Dementia

Pharmacological Treatment of Behavioural and Psychological Symptoms of Dementia (BPSD) Gurdeep K Major St. Charles Hospital

Supplementary Online Content

Supplementary Online Content

Supplementary Online Content

The use of prescription databases for the study of prescription drug abuse: Prescriptions of Benzodiazepines in Denmark

OLD AGE PSYCHIATRY. Dementia definition TYPES OF DEMENTIA. Other causes. Psychiatric disorders of the elderly. Dementia.

NICE Quality Standards and commissioning dementia care

Supplementary Methods

Supplementary Appendix

Pharmacy Prior Authorization GMH/SA and Non-Title 19/21 SMI Non-Formulary and Prior Authorization Guidelines

Pharmacological Treatment of Aggression in the Elderly

NICE Medicines Guidance

Dementia Care Pathway

Literature Scan: Alzheimer s Drugs

Neurocognitive Disorders Research to Emerging Therapies

Prescribing for people with dementia. Carol Paton Chief Pharmacist April 2009

MEDICATIONS PRESCRIPTION AT HOSPITAL DISCHARGE IN PATIENTS WITH VALIDATED DIAGNOSIS OF DEMENTIA. Federica Edith Pisa University Hospital Udine

Office Practice Coding Assistance - Overview

Rational Medication Use in Dementia

Supplementary Online Content

Vascular Dementia. Laura Pedelty, PhD MD The University of Illinois at Chicago and Jesse Brown VA Medical Center

Supplementary Appendix

See Important Reminder at the end of this policy for important regulatory and legal information.

Mental Disorders with Associated Harmful Behavior and Substance-Related Disorders

Supplementary Online Content

INDIANA HEALTH COVERAGE PROGRAMS

Summary of 2012/13 QOF Changes

Essential Shared Care Agreement Drugs for Dementia

Community Pharmacy Dementia Audit

Drugs used to relieve behavioural and psychological symptoms in dementia

Memory Loss, Dementia and Alzheimer's Disease: The Basics

GERIATRIC MEDICINE FOR PRIMARY CARE. Chicago, Illinois The Gwen, A Luxury Collection Hotel, Chicago June 22 24, 2018

DRUG THERAPY CHOICES FOR THE DEMENTED PATIENT Past, Present and Future

Neil Drummond PhD, Richard Birtwhistle MD MSc, Tyler Williamson PhD, Shahriar Khan MSc MA, Stephanie Garies MPH, Frank Molnar MSc MDCM

Supplementary Online Content

NEUROLOGY & PSYCHIATRY FOR PRIMARY CARE. San Diego, California Hotel del Coronado December 8 10, 2017

Supplementary Online Content

European Collaboration on Dementia. Luxembourg, 13 December 2006

Essential Shared Care Agreement Drugs for Dementia

Interface Prescribing Subgroup DRUGS FOR DEMENTIA: INFORMATION FOR PRIMARY CARE

Dementia: It s Not Always Alzheimer s

NEURO/PSYCH FOR PRIMARY CARE. San Juan, Puerto Rico InterContinental San Juan February 25 28, 2016

NEUROLOGY & PSYCHIATRY FOR PRIMARY CARE. Vail, Colorado Hotel Talisa February 9 11, 2018

Supplementary Figure 1. Kaplan Meier plots of the association of anti-inflammatory medication (acetyl salicylic acids (ASA), non-steroid

Supplementary Online Content

Supplementary Online Content

Author Appendix Contents. Appendix A. Model fitting results for Autism and ADHD by 8 years old

Pharmacological Treatment of Dementia

Clinical Policy: Rivastigmine (Exelon) Reference Number: CP.PMN.101 Effective Date: Last Review Date: 02.18

Nuplazid. Nuplazid (pimavanserin) Description

Effective Shared Care Agreement (ESCA) for drugs used in dementia- Donepezil, Galantamine, Rivastigmine and Memantine

Dementia NICE Guidelines Update. Key points for primary care - NICE guideline (June 2018 update ) 26 September 2018

MODEL PSYCHOPHARMACOLOGY CURRICULUM

Psychotropic Medication Use in Dementia

Coping with Alzheimer s Disease in the Internet Age Survey Results

SHARED CARE PROTOCOL CHOLINESTERASE INHIBITORS IN ALZHEIMER S DEMENTIA

DERBYSHIRE JOINT AREA PRESCRIBING COMMITTEE (JAPC) JAPC Briefing FreeStyle Libre

Supplementary Online Content

Supplementary Online Content

Appendix C: Algorithms. Algorithm C-1: Enhanced Screening Algorithm

Supplementary Online Content

Alcoholism. Psychiatry. Alcoholism. Alcoholism. Certification. Certification

WHEN THE GOING GETS TOUGH: Working Through the Challenges of Dementia Together. Presented by

Table S1: Diagnosis and Procedure Codes Used to Ascertain Incident Hip Fracture

Supplementary Online Content

Transcription:

Supplementary Online Content Ribe AR, Laursen TM, Charles M, et al. Long-term risk of dementia in persons with schizophrenia: a Danish population-based cohort study. JAMA Psychiatry. Published online October 7, 2015. doi:10.1001/jamapsychiatry.2015.1546. etable 1. Information on Schizophrenia Obtained From the Danish Psychiatric Central Research Register etable 2. Information on Dementia Obtained From the Danish Psychiatric Central Research Register, the Danish National Patient Register, and the Danish National Prescription Registry etable 3. Information on Comorbidity (ie, Other Risk Factors for Dementia) Obtained From the Danish National Patient Register, the Danish National Diabetes Register and the Danish Psychiatric Central Register etable 4. Information on Diabetes Obtained From the Danish National Diabetes Register etable 5. Information on Substance Abuse Disorders Obtained From the Danish National Patient Register and the Danish Psychiatric Central Research Register This supplementary material has been provided by the authors to give readers additional information about their work 2015 American Medical Association. All rights reserved. 1

etable 1. Information on Schizophrenia Obtained From the Danish Psychiatric Central Research Register Schizophrenia 295 (excluding 295.79) F20 Schizoaffective disorders 295.79, 296.8 F25 Persons with other psychiatric diseases, such as depression or bipolar affective disorder were not excluded from the study and were thus part of the group of persons without schizophrenia. 2015 American Medical Association. All rights reserved. 2

etable 2. Information on Dementia Obtained From the Danish Psychiatric Central Research Register, the Danish National Patient Register, and the Danish National Prescription Registry A diagnosis of dementia was identified if at least one of the following criteria was met: 1. Registration of a diagnosis of dementia in the Danish Psychiatric Central Register or the Danish National Patient Register. And/or 2. Registration of at least one prescription of anti-dementia drug redeemed in the Danish National Prescription Registry. Diagnosis according to a record of dementia in the Danish Psychiatric Central Register or the Danish National Patient Register. AD (Alzheimer s disease) 290.10 F00.0, F00.1, F00.2, F00.9, G30.0, G30.1, G30.8, G30.9 VaD (vascular dementia) 293.09-19 F01.0, F01.1, F01.2, F01.3, F01.8, F01.9 FTD (frontotemporal dementia) 290.11 F02.0 Dementia without specification 290.09-19 F03.9 Diagnosis according to a record of prescriptions for anti-dementia drugs in the Danish National Prescription Registry: Name Drug name ATC-codes Anticholinesterases Tacrine N06DA01 Donepezile N06DA02 Rivastigmine N06DA03 Other anti-dementia drugs Galantamine Donepezile and Memantine Memantine N06DA04 N06DA52 N06DX1 2015 American Medical Association. All rights reserved. 3

etable 3. Information on Comorbidity (ie, Other Risk Factors for Dementia) Obtained From the Danish National Patient Register, the Danish National Diabetes Register and the Danish Psychiatric Central Register Ischemic heart disease 410 414 I20 I25 Congestive heart failure 427.09, 427.10, 427.11, 427.19, 428.99, 782.49 I50, I11.0, I13.0, I13.2 Atrial fibrillation or flutter 427.93, 427.94 I48 Peripheral vascular disease 440, 441, 442, 443, 444, 445 I70, I71, I72, I73, I74, I77 Cerebrovascular disease 430-438 I60-I69, G45, G46 Diabetes See Appendix 4 Substance abuse disorder See Appendix 5 2015 American Medical Association. All rights reserved. 4

etable 4. Information on Diabetes Obtained From the Danish National Diabetes Register Algorithm: Individuals were classified as having diabetes on the date when at least one of the following six criteria was met: 1. A diagnosis of diabetes made at any Danish hospital registered in the Danish National Patient Register (:249, 250; :E10-14, H36.0, O24, excluding O24.4). 2. A referral to chiropody of diabetic patients as registered in the Danish National Health Service Register. 3. Five blood glucose measurements within one year registered in the Danish National Health Service Register. 4. Two blood glucose measurements per year for five consecutive years registered in the Danish National Health Service Register. 5. Two redemptions of oral anti-diabetic drugs within six months registered in the Danish National Prescription Registry. 6. Two redemptions of prescribed insulin registered in the Danish National Prescription Registry. 2015 American Medical Association. All rights reserved. 5

etable 5. Information on Substance Abuse Disorders Obtained From the Danish National Patient Register and the Danish Psychiatric Central Research Register Drug-related abuse Opioids 304.09, 304.19 F11.0 F11.9 Cannabinoids 304.59 F12.0 F12.9 Sedatives/hypnotics 304.29, 304.39 F13.0 F13.9 Cocaine 304.49 F14.0 F14.9 Other stimulants 304.69 F15.0 15.9 Hallucinogens 304.79 F16.0 F16.9 Other and multiple drugs 304.89, 304.99 F18.0 F19.9 Alcohol-related abuse Alcohol psychosis and abuse syndrome 291.09 291.99 F10.0 F10.9 303.09 303.99 Cirrhosis and steatosis of the liver 571.09, 571.10, 571.19 K70.0 K70.9 Esophageal varices 456.00, 456.01, 456.09 I85.0 I85.9 2015 American Medical Association. All rights reserved. 6